Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Novavax Inc (NVAX)

NASDAQ
Symbol
Exchange
Currency
NVAXNASDAQUSD
NVV1TradeGateEUR
Currency in USD
Disclaimer
4.150
-0.040(-0.95%)
Closed
After Hours
4.090-0.060(-1.451%)

NVAX Comments

Expect above 20 from next week and below six if you don't see European confirmations.
Why confirmation of Europe affect too much?
Because it is a long-term contract
I said it will be red again, thank you Novavax.If you do the same thing in a few months, I will cross the hundred thousand dollar mark.
hahahahaha
Which person buys from Novavax.. a company that went from 300 dollars to 6 dollars. I never buy.
but are you selling?
Which idiot buys Novavax.. a company that went from $300 to $6
Look at the historical data of the last 27 years.
The size of their income shows a continuous, stable upward trajectory. ( It is true that their expenses are also increasing. So not everything is working well at the company. ) But it is no more crazy to buy Novavax for $6 than Tesla for over $150.
The next day is red
It will turn red in a few hours. 6.38
first hores coming hhhhh. buy the dip
don't get your hopes up
12 day to earnings
buy the dip🚀
Who is the first horse?
There is no comment. I think when it moves up, horse come with comments.
One month later
 one month later?
Next month yes
There is no county. I think when it moves up, idiots come with comments.
hhhhhhhhhh I loved
It is coming, crash the shots
There is no mail, all purchases went underground. I m 👿 I loved
Let's crash shorters. The short squeeze is coming
buy dip, great future company🚀🚀
 So guys it will never rise again? what is this, we were talking about 20-25 dollars? No covid no profit, they just sell covid vaccine, come on what about their other studies for vaccination?
 this does not mean Novavax will go down further, no?
I find it ridiculous that covid is used as data when talking about investing in a vaccine manufacturing company. You have to look at the data of the last 27 years. The covid actually burst into the public consciousness in 2019. The price of the company's shares ranges between ~$6 and ~$200 with a continuous 3-6 year cycle. It's been 27 years...
So the plan is to get rid of retailers but is it bad to invest this company why they want to get rid of them?
go to 5.77....
ahaha
I will get another loan to buy more then I will be in debt
Short squeeze is coming
go on till ? Estimation?
5.77
 yes it is going. So never back to 10. It is like 100%
steep dive
thanks for  making relax.
 go to 5.77))
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United Kingdom
ok it means it will drop more after those good news
where are you Nikolay ?
what do yoy want
hi Bendji, i`m there)))
i'm there, go to sleep, Benji
...
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.